| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Vandetanib |
|
443913-73-3 |
詳細(xì)
|
| ARV766 |
|
2750830-09-0 |
詳細(xì)
|
| Pneumocandin A0 |
|
539823-80-8 |
詳細(xì)
|
| Bufotaline |
|
471-95-4 |
詳細(xì)
|
| DRB |
二氯苯并咪唑呋喃型核糖苷 |
53-85-0 |
詳細(xì)
|
| DEOXYNIVALENOL |
|
51481-10-8 |
詳細(xì)
|
| Baloxavir |
|
1985605-59-1 |
詳細(xì)
|
| Bezuclastinib |
|
1616385-51-3 |
詳細(xì)
|
| Anakinra |
|
143090-92-0 |
詳細(xì)
|
| (+)-15(S)-CLOPROSTENOL |
|
54276-22-1 |
詳細(xì)
|
| Bedaquiline |
貝達(dá)喹啉 |
843663-66-1 |
詳細(xì)
|
| JZL 184 |
|
1101854-58-3 |
詳細(xì)
|
| Delafloxacin |
德拉沙星 |
189279-58-1 |
詳細(xì)
|
| TRANS-N-BOC-1,4-CYCLOHEXANEDIAMINE |
反式-(4-氨基環(huán)己基)氨基甲酸叔丁酯 |
177906-48-8 |
詳細(xì)
|
| C-GPAP |
|
849214-04-6 |
詳細(xì)
|
| Milademetan |
|
1398568-47-2 |
詳細(xì)
|
| Fructosazine |
|
13185-73-4 |
詳細(xì)
|
| PHYSOSTIGMINE SALICYLATE |
|
57-64-7 |
詳細(xì)
|
| DDE-OH |
1，1-二氯-2，2-雙(4-氯苯基)乙烯 |
94142-97-9 |
詳細(xì)
|
| [2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid |
[2-[2-(Fmoc-氨基)乙氧基]乙氧基]乙酸 |
166108-71-0 |
詳細(xì)
|
| Veliparib |
維利帕尼 |
912444-00-9 |
詳細(xì)
|
| AZD8931 |
|
848942-61-0 |
詳細(xì)
|
| Cedazuridine |
西達(dá)尿苷 |
1141397-80-9 |
詳細(xì)
|
| BDCRB (GW 275175) |
|
142356-43-2 |
詳細(xì)
|
| FMOC-ORN(DDE)-OH |
N-芴甲氧羰基-(N'-1-(4,4-二甲基-2,6-二氧代環(huán)己-1-亞基)乙基)-L-鳥(niǎo)氨酸 |
269062-80-8 |
詳細(xì)
|
| Propanamide, 3-[[6-chloro-8-fluoro-7-(2-fluoro-6-hydroxyphenyl)-4-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-2-quinazolinyl]amino]-N-methyl-N-2-propyn-1-yl- |
|
2436544-27-1 |
詳細(xì)
|
| L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, 1-ethyl ester |
|
65148-63-2 |
詳細(xì)
|
| dCBP-1 |
|
2484739-25-3 |
詳細(xì)
|
| paltusotine |
|
2172870-89-0 |
詳細(xì)
|
| STC-15 |
|
2648257-56-9 |
詳細(xì)
|
| GW274150 |
乙酰基半胱氨酸雜質(zhì)4 |
210354-22-6 |
詳細(xì)
|
| Elesclomol |
|
488832-69-5 |
詳細(xì)
|
| SOLIFENACIN |
|
180272-14-4 |
詳細(xì)
|
| Unii-na83F1sjsr |
|
706782-28-7 |
詳細(xì)
|
| N-alpha-Fmoc-N-epsilon-4-methoxytrityl-L-lysine |
N-[(9H-芴-9-基甲氧基)羰基]-N'-[(4-甲氧基苯基)二苯基甲基]-L-賴氨酸 |
159857-60-0 |
詳細(xì)
|
| Dabrafenib (free base) |
|
1195765-45-7 |
詳細(xì)
|
| Auristatin E |
|
160800-57-7 |
詳細(xì)
|
| DL-2-Amino-5-phosphonopentanoic acid |
DL-2-氨基-5-膦?；i草酸 |
76326-31-3 |
詳細(xì)
|
| ALLOPREGNANOLONE |
|
516-55-2 |
詳細(xì)
|
| INDEX NAME NOT YET ASSIGNED |
|
2301113-15-3 |
詳細(xì)
|
| Toceranib Phosphate |
|
874819-74-6 |
詳細(xì)
|
| Q203 |
|
1334719-95-7 |
詳細(xì)
|
| ARQ-531 |
|
2095393-15-8 |
詳細(xì)
|
| 5-methyl-1H-pyrazole-4-sulfonamide |
5-甲基-1H-吡唑-4-磺酰胺 |
1935987-67-9 |
詳細(xì)
|
| Trilostane |
|
13647-35-3 |
詳細(xì)
|
| Research Grade Pamrevlumab |
|
946415-13-0 |
詳細(xì)
|
| (R)-methyl piperidine-3-carboxylate |
(R)-哌啶-3-甲酸甲酯 |
164323-85-7 |
詳細(xì)
|
|
中間體 |
52063-45-3 |
詳細(xì)
|
| pneumocandin C(0) |
|
144074-96-4 |
詳細(xì)
|
| 2-Hydrazinyl-4,5-dlhydro-1H-1.3-benzodiazepine |
|
120075-92-5 |
詳細(xì)
|
| 1-(4-Aminophenyl)-1,2,2-triphenylethene |
1-(4-氨基苯)-1,2,2-三苯乙烯 |
919789-80-3 |
詳細(xì)
|
| FMOC-THR(TBU)-OL |
N-[(1R,2R)-2-(1,1-二甲基乙氧基)-1-(羥基甲基)丙基]氨基甲酸 9H-芴-9-甲酯 |
189337-28-8 |
詳細(xì)
|
| 2-(2-(6-chlorohexyloxy)ethoxy)ethanamine |
1-[2-(2-氨基乙氧基)乙氧基]-6-氯己烷 |
744203-60-9 |
詳細(xì)
|
| MGV354 |
|
1852495-86-3 |
詳細(xì)
|
| GW274150 phosphate |
|
438542-15-5 |
詳細(xì)
|
| GW274150 dihydrochloride |
|
438542-17-7 |
詳細(xì)
|
| N,N,N',N'-Tetrakis[4-(dibutylamino)phenyl]benzene-1,4-diamine |
N,N,N',N'-四(4-二丁基氨基苯基)-1,4-苯二胺 |
4182-80-3 |
詳細(xì)
|
| 6-Hydroxy-DL-DOPA |
N,N-二甲基甲酰胺二甲縮醛 |
21373-30-8 |
詳細(xì)
|
| LORCASERIN |
|
616202-92-7 |
詳細(xì)
|
| Imidazo[1,5-a]pyridine-7-carboxylic acid |
咪唑并[1,5-a]吡啶-7-羧酸 |
588720-29-0 |
詳細(xì)
|
| Saracatinib |
塞卡替尼 |
379231-04-6 |
詳細(xì)
|
| BAF-312(SiponiMod) |
|
1230487-00-9 |
詳細(xì)
|
| Etrasimod |
|
1206123-37-6 |
詳細(xì)
|
| L-Valine methyl ester hydrochloride |
L-纈氨酸甲酯鹽酸鹽 |
6306-52-1 |
詳細(xì)
|
| T-2 TOXIN |
|
21259-20-1 |
詳細(xì)
|
| JSH-150 |
|
2247481-21-4 |
詳細(xì)
|
| Bemnifosbuvir hemisulfate |
|
2241337-84-6 |
詳細(xì)
|
| Safinamide |
|
133865-89-1 |
詳細(xì)
|
| Fludarabine-Cl |
磷酸氟達(dá)拉濱雜質(zhì)35 |
2734853-80-4 |
詳細(xì)
|
| Bipenquinate |
|
96201-88-6 |
詳細(xì)
|
| 2-(3-METHYLBUTYRYL)-5,5-DIMETHYL-1,3-CYCLOHEXANDIONE |
DMAB-OH |
172611-72-2 |
詳細(xì)
|
| 2,3,4,5-TETRAHYDRO-1H-BENZO[E][1,4]DIAZEPINE |
2,3,4,5-四氫-1H-苯并[E][1,4]二氮雜卓 |
1904-65-0 |
詳細(xì)
|
| Efavirenz |
|
154598-52-4 |
詳細(xì)
|
| 5-Bromo-1H-pyrrolo[2,3-b]pyridine-2,3-dione |
5-溴-1H-吡咯并[2,3-b]吡啶-2,3-二酮 |
149142-67-6 |
詳細(xì)
|
| Ivabradine IMpurity |
|
1616710-50-9 |
詳細(xì)
|
| Afoxolaner |
阿弗拉納 |
1093861-60-9 |
詳細(xì)
|
| Tolebrutinib |
|
1971920-73-6 |
詳細(xì)
|
| Pyrazinamide |
|
98-96-4 |
詳細(xì)
|
| Zoledronic Acid Impurity 1 |
唑來(lái)膦酸雜質(zhì)A |
1627731-60-5 |
詳細(xì)
|
| Argatroban |
|
74863-84-6 |
詳細(xì)
|
| ROTIGOTINE |
|
99755-59-6 |
詳細(xì)
|
| Axitinib |
|
319460-85-0 |
詳細(xì)
|
| SHEN26 |
|
2647441-36-7 |
詳細(xì)
|
| EN523 |
|
2094893-05-5 |
詳細(xì)
|
| JNK-IN-8 |
|
1410880-22-6 |
詳細(xì)
|
| Ceritinib (LDK378) |
|
1032900-25-6 |
詳細(xì)
|
| DDE-LYS(FMOC)-OH |
|
156648-40-7 |
詳細(xì)
|
| CCS-1477 |
|
2222941-37-7 |
詳細(xì)
|
| DIABZI STING AGONIST-1 |
|
2138299-33-7 |
詳細(xì)
|
| 4'-C-Fluoro-uridine |
|
1613589-24-4 |
詳細(xì)
|
| Fmoc-L-Lys(Dde)-OH |
N-FMOC-N'-[1-(4,4-二甲基-2,6-二氧代環(huán)己亞基)乙基]-L-賴氨酸 |
150629-67-7 |
詳細(xì)
|
| FMOC-LYS(IVDDE)-OH |
N-芴甲氧羰基-N'-[1-(4,4-二甲基-2,6-二氧代環(huán)己基亞甲基)-3-甲基丁基]-L-賴氨酸 |
204777-78-6 |
詳細(xì)
|
| Florfenicol |
|
73231-34-2 |
詳細(xì)
|
| Nilvadipine |
|
75530-68-6 |
詳細(xì)
|
| 2,5-dianilinocyclohexa-2,5-diene-1,4-dione |
2,5-二苯胺基環(huán)己-2,5-二烯-1,4-二酮 |
3421-08-7 |
詳細(xì)
|
| AZD1480 |
|
935666-88-9 |
詳細(xì)
|
| Bedaquiline fumarate |
富馬酸貝達(dá)喹啉 |
845533-86-0 |
詳細(xì)
|
| ivDde-Lys(Fmoc)-OH |
|
1446752-60-8 |
詳細(xì)
|
| 1,3-dihydro-6-methylfuro[3,4-c]pyridin-7-ol hydrochloride |
|
1006-21-9 |
詳細(xì)
|
| Ciclesonide |
|
141845-82-1 |
詳細(xì)
|